Page last updated: 2024-12-06

alpha-methylfentanyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpha-methylfentanyl: combined with 3-methylfentanyl & sold as illicit China White [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62281
CHEMBL ID2022411
SCHEMBL ID928197
MeSH IDM0099237

Synonyms (31)

Synonym
n-(1-(1-methyl-2-phenylethyl)-4-piperidinyl)-n-phenylpropanamide
n-[1-(1-methyl-2-phenyl-ethyl)-4-piperidyl]-n-phenyl-propanamide
DB01557
alpha-methylfentanyl
79704-88-4
alpha methyl fentanyl
n-phenyl-n-[1-(1-phenylpropan-2-yl)piperidin-4-yl]propanamide
CHEMBL2022411
1-(1-methyl-2-phenylethyl)-4-(n-propanilido)piperidine
propanamide, n-(1-(1-methyl-2-phenylethyl)-4-piperidinyl)-n-phenyl-
unii-8fu589w85c
8fu589w85c ,
dea no. 9814
n-(1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl)propionanilide
SCHEMBL928197
propanamide, n-phenyl-n-[1-(1-phenylprop-2-yl)-4-piperidinyl]-
.alpha.-methylfentanyl
NGTVDHYUFBKWID-UHFFFAOYSA-N
AKOS028114493
DTXSID60273955
propanamide, n-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-n-phenyl-
n-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-n-phenyl-propanamide
Q3730799
n-phenyl-n-[1-[(2s)-1-phenylpropan-2-yl]piperidin-4-yl]propanamide
china-white
ids-na-016
acscn-9814
.alpha.-methylfentanyl [mi]
n-(1-(.alpha.-methylphenethyl)-4-piperidyl)propionanilide
methylfentanyl, .alpha.-
(+/-)-.alpha.-methylfentanyl
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID660344Drug excretion in rat urine assessed as N-dealkylated norfentanyl metabolite release at 3 mg/kg, po measured every 24 hrs for 96 hrs2011ACS medicinal chemistry letters, Aug-11, Volume: 2, Issue:8
Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (22.22%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]